Emily Rogalski, PhD

  • Rosalind Franklin PhD Professor of Neurology
    Professor of Neuroscience Institute
    Committee on Neurobiology
  • Research and Scholarly Interests: Aging Well, Aging, Healthy, Alzheimer Dementia, Alzheimer Disease, Behavoiral intervention, Caregiver, Cognitive Functions, Communication, Partner, Community Health, Frontotemporal Dementia, Magnetic Resonance Imaging, Neurology, Neuropsychology, Neuroscience, Positron Emission Tomography, Primary Progressive Aphasia, Randomized Controlled Trial, Social Work, Speech Language Pathology, SuperAging
  • Websites: Healthy Aging & Alzheimer's Research Care Center, Research Network Profile
  • Contact: erogalski@uchicago.edu
  • Graduate Programs: Neurobiology, PhD Program in Neurobiology

Democratizing dementia research through global online conferences.
Democratizing dementia research through global online conferences. Nat Neurosci. 2025 May 05.
PMID: 40325214

Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia.
Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia. Alzheimers Dement. 2025 Apr; 21(4):e14608.
PMID: 40277074

Triadic Primary Care Encounters Managing Medications among Individuals with Mild Cognitive Impairment and Dementia: Patient, Caregiver and Clinician Perspectives.
Triadic Primary Care Encounters Managing Medications among Individuals with Mild Cognitive Impairment and Dementia: Patient, Caregiver and Clinician Perspectives. Gerontologist. 2025 Mar 28.
PMID: 40177942

Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.
Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts. Ann Neurol. 2025 Mar 17.
PMID: 40091774

The causal association between resting state intrinsic functional networks and neurodegeneration.
The causal association between resting state intrinsic functional networks and neurodegeneration. Brain Commun. 2025; 7(2):fcaf098.
PMID: 40103583

Amyloid PET predicts longitudinal functional and cognitive trajectories in a heterogeneous cohort.
Amyloid PET predicts longitudinal functional and cognitive trajectories in a heterogeneous cohort. Alzheimers Dement. 2025 Mar; 21(3):e70075.
PMID: 40145384

Efficacy of Communication Bridge-2 for primary progressive aphasia: A randomized controlled trial of communication intervention.
Efficacy of Communication Bridge-2 for primary progressive aphasia: A randomized controlled trial of communication intervention. Alzheimers Dement. 2025 Mar; 21(3):e70088.
PMID: 40145390

Dissociable spatial topography of cortical atrophy in early-onset and late-onset Alzheimer's disease: A head-to-head comparison of the LEADS and ADNI cohorts.
Dissociable spatial topography of cortical atrophy in early-onset and late-onset Alzheimer's disease: A head-to-head comparison of the LEADS and ADNI cohorts. Alzheimers Dement. 2025 Feb; 21(2):e14489.
PMID: 39968692

Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials.
Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials. J Prev Alzheimers Dis. 2025 Apr; 12(4):100075.
PMID: 39956674

Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer's disease: a neuropsychological data-driven approach.
Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer's disease: a neuropsychological data-driven approach. Alzheimers Res Ther. 2025 Feb 06; 17(1):38.
PMID: 39915859

View All Publications